DONNA CAMBRON: Open Payments
NPI 1093721136 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $411 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $192 |
| E.R. Squibb & Sons, L.L.C. | 2 | $135 |
| Novo Nordisk Inc | 1 | $120 |
| Lilly USA, LLC | 1 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| CARDIVA MEDICAL, INC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: Ozempic, WATCHMAN FLX, ZEPBOUND, OptiCross, Kerendia, AVVIGO Guidance System, ONPATTRO, CARDIVA VASCADE 6/7F VCS.
Industry payments across SC — which companies pay providers there.
